GlaxoSmithKline Uses Clinical Graphics Solution Developed by Insightful Corporation

SEATTLE--(BUSINESS WIRE)--Insightful Corporation (NASDAQ:IFUL), a leading provider of predictive analytics and reporting solutions, announced today that GlaxoSmithKline (GSK), one of the world’s leading research-based pharmaceutical and healthcare companies, is using a clinical graphics solution developed by Insightful and S-PLUS®, Insightful’s software platform for statistical data analysis and predictive analytics, to speed the design, analysis, and reporting of clinical trial data.